MT2A and chronic kidney disease: Hattori and colleagues conducted two studies, one longitudinal and the other cross-sectional, to evaluate the association between metallothionein 2A (MT2A) rs28366003 and the risk of CKD in a cohort of 2774 DM patients residents in Nagoya City, Japan [31].